Granted, that statistic was affected by COVID-19, but chronic disease played a significant role as well
La fenilcetonuria es una enfermedad hereditaria, lo cual significa que se transmite de padres a hijos
A species/strain comparison of hepatic natural lymphocytotoxic activities in rats and mice
Vitamin B12 $60 Vitamin B12 allows the body to use fat and carbohydrates for energy and making new protein
Sa production est toutefois diminue avec lge, et dans certains cas, elle demeure insuffisante pour dfendre correctement lorganisme
Legitimate Research Directions: Some peptides DO have potential and are being properly studied: Thymosin Alpha-1: Immune support (approved in 35+ countries, trials in US) BPC-157: IF proper human trials ever happen LL-37: Antimicrobial applications Others: Many peptides have theoretical promise But ONLY if studied properly: Randomized controlled trials Safety studies FDA approval process Medical supervision The Problem: Most "wellness peptides" will NEVER go through this process because: They can't be patented (no profit incentive) Companies would rather sell in gray market Proper trials cost $100M+ If trials show they DON'T work, the market disappears So we're stuck in limbo: promising animal data, zero human data, aggressive marketing
